Akebia Therapeutics, Inc. (AKBA)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 263.04M |
| Enterprise value | 268.24M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.21 |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | 1.38 |
| Enterprise value/EBITDA | -66.28 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.84 |
| 52-week change 3 | 43.18% |
| S&P500 52-week change 3 | 23.10% |
| 52-week high 3 | 2.4800 |
| 52-week low 3 | 0.7800 |
| 50-day moving average 3 | 1.5662 |
| 200-day moving average 3 | 1.3250 |
Share statistics
| Avg vol (3-month) 3 | 4.93M |
| Avg vol (10-day) 3 | 2.57M |
| Shares outstanding 5 | 209.37M |
| Implied shares outstanding 6 | 209.6M |
| Float 8 | 189.47M |
| % held by insiders 1 | 1.93% |
| % held by institutions 1 | 26.62% |
| Shares short (15 Apr 2024) 4 | 13.69M |
| Short ratio (15 Apr 2024) 4 | 1.42 |
| Short % of float (15 Apr 2024) 4 | 6.61% |
| Short % of shares outstanding (15 Apr 2024) 4 | 6.54% |
| Shares short (prior month 15 Mar 2024) 4 | 10.13M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -26.68% |
| Operating margin (ttm) | 5.26% |
Management effectiveness
| Return on assets (ttm) | -9.31% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 194.62M |
| Revenue per share (ttm) | 1.04 |
| Quarterly revenue growth (yoy) | 0.70% |
| Gross profit (ttm) | N/A |
| EBITDA | -6.87M |
| Net income avi to common (ttm) | -51.92M |
| Diluted EPS (ttm) | -0.2800 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 42.92M |
| Total cash per share (mrq) | 0.2 |
| Total debt (mrq) | 104.18M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 1.18 |
| Book value per share (mrq) | -0.16 |
Cash flow statement
| Operating cash flow (ttm) | -23.38M |
| Levered free cash flow (ttm) | 22.11M |
© 2024 Yahoo. All rights reserved.